Galunisertib is an orally available, small molecule antagonist of the tyrosine kinase transforming growth factor-beta (TGF-b) receptor type 1 (TGFBR1), with potential antineoplastic activity. The directory classifies it as a discontinued API with a synthetic source/manufacturing origin. Other names for this substance include Inhibitor 15d and LY-2157299. Its PubChem CID is 10090485.
Galunisertib
| CAS No | 700874-72-2 |
|---|---|
| Molecular Formula | C22H19N5O |
| Molecular Weight | 369.4 g/mol |
| Synonyms | 4-[2-(6-methyl-2-pyridinyl)-5,6-dihydro-4H-pyrrolo[1,2-b]pyrazol-3-yl]quinoline-6-carboxamide |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Galunisertib is an orally available, small molecule antagonist of the tyrosine kinase transforming growth factor-beta (TGF-b) receptor type 1 (TGFBR1), with potential antineoplastic activity.
The listed CAS number is 700874-72-2.
The listed molecular formula is C22H19N5O.
The listed molecular weight is 369.4 g/mol.
4-[2-(6-methyl-2-pyridinyl)-5,6-dihydro-4H-pyrrolo[1,2-b]pyrazol-3-yl]quinoline-6-carboxamide.
The source lists Inhibitor 15d and LY-2157299.